Lilly Welcomes Request from Senators About Insulin Affordability Programs
Lilly Welcomes Request from Senators About Insulin Affordability Programs
September 29, 2023
On August 31, 2023, Lilly received a letter, also addressed to Novo Nordisk and Sanofi, from Senators Elizabeth Wood Hassan and Tina Smith requesting information about manufacturers’ patient assistance programs for insulin. Lilly welcomes questions about our insulin affordability solutions so that more people with diabetes know how easy it is to access them, and we responded with this letter to the senators.